Previous studies indicated that SIX1 overexpression was positively correlated with liver cancer prognosis and survival.20,21 A previous study showed that CD90 expressions significantly increase in liver tumor tissue compared to its paired normal tissue.22 The sphere analyses demonstrate that the SIX1 downregulation caused the inhibition of the CD90 protein level. Here, THY1 is linked to liver cancer.